Lemierre syndrome: summary of the main clinical evidences
Keywords:Medical Clinic, Lemierre Syndrome, Diagnosis, Treatment
Introduction: Lemierre syndrome (SL) originates as a complication of bacterial infections in the oropharynx. The disease is associated with anaerobic septicemia and death in young, healthy patients, and can quickly evolve to death if not diagnosed and treated quickly. Aim: To conduct a review of recent literature seeking to synthesize the main clinical evidence related to Lemierre's Syndrome. Method: The selection of papers was carried out on December 6, 2020. The database used in the search was PUBMED, using the following strategy: "lemierre's syndrome" [title]. Of the 17 articles initially selected, one was eliminated for discussing SL specifically related to trauma, and another that indicated a publication probably portrayed by the authors, which was not available for consultation. Conclusions: The diagnosis of SL is usually made with the aid of cervical or thoracic computed tomography to identify the emboli and thrombi, magnetic resonance imaging to identify the venous thrombi, and blood culture to identify the causative microorganisms. Regarding treatment, although there are no defined guidelines for SL, prolonged administration of intravenous antibiotics is essential, and surgical procedures are sometimes necessary. Anticoagulant therapy for the treatment of thrombi depends on the situation, since there are divergences regarding its usefulness. Regarding pharmacotherapeutic regimens, Fusobacteria necrophorum (FN) is generally susceptible to penicillin, clindamycin, metronidazole and chloramphenicol, and it is suggested that its use be carried out in conjunction with a beta-lactamase inhibitor. Gemella bergeri (GB) and Eikenella corrodens (EC) were reactive to meropenem, clindamycin and vancomycin, and methicillin-resistant Staphylococcus aureus (MRSA) was susceptible to cefazolin (which can also be applied to FN).
How to Cite
Authors who publish in this journal agree to the following terms: The author(s) authorize the publication of the text in the journal; The author(s) guarantee that the contribution is original and unpublished and is not in the process of being evaluated by any other journal(s); The journal is not responsible for the opinions, ideas, and concepts contained in the texts, as these are the sole responsibility of their respective author(s); The editors reserve the right to make adjustments to the text in order to ensure that it adheres to the standards of the journal. Authors retain the copyrights and grant the journal the right of first publication, with the article simultaneously licensed under the Creative Commons Attribution License which allows the sharing of the article with the acknowledgment of authorship and initial publication in this journal. Authors are authorized to take additional contracts separately, for the non-exclusive distribution of the version of the article published in this journal (e.g. publication in an institutional repository or as a book chapter), with the acknowledgment of authorship and initial publication in this journal.
Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal webpage) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and citation of published work (See The Effect of Free Access at http://opcit.eprints.org/oacitation-biblio.html)